In STREAM stage 2, this study compared two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen. Both bedaquiline-containing regimens, a 9-month oral regimen and a 6-month regimen with 8 weeks of second-line injectable, had superior efficacy compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss.
Published: November 8, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Quick Reference Guide and Checklist for CRVS and ID Systems Improvement Framework
Tobacco Control Case Study: Vietnam – E-Cigarette Message Testing Guides Policymaking
Public Opinion Poll Results on Alcohol Consumption in Sri Lanka
Vital Strategies: Reimagine Public Health
Reducing Overdose Among People In Probation Supervision
Black communities in Milwaukee, Wisconsin join together to address the needs of Black…
Road Safety Social Media Campaign Guidance
A new tool for evaluating health equity in academic journals; the Diversity Factor
The Role of Mass Media Campaigns in Reducing Traffic Crashes and How to…
Information about Over the Counter Naloxone